Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Therakos has announced receipt of a CE Mark in Europe for Therakos Cellex photopheresis system, a therapy for the treatment of patients with immune-mediated diseases.
Subscribe to our email newsletter
The system will be used for the treatment of immune-mediated diseases such as acute or chronic graft-versus-host disease and cutaneous T-cell lymphoma.
Therakos Cellex photopheresis system is the next generation in a product line that offers the only validated, automated and integrated systems that are CE Marked to perform extracorporeal photopheresis, according to Therakos.